FDA Panel Recommends Novavax COVID-19 Vaccine be the Fourth Allowed for Use in US
A federal advisory committee recommended Tuesday that a fourth COVID-19 vaccine be authorized for use in the USA, this one from Novavax, a company based in Gaithersburg, Maryland. Great!
Comments